MarketCap
Facebook
X
Telegram
AnaptysBio EV | ANAB
EV Jährlich AnaptysBio
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.46 B | 1.38 B | 438 M | 593 M | 629 M | 457 M | 336 M | 253 M | 1.52 B | 2.05 B | 283 M | -37.8 M | 19.1 M | 3.77 M | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.05 B | -37.8 M | 670 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Protara Therapeutics
TARA
|
208 M | $ 2.61 | 7.41 % | $ 112 M |  USA |
 |
Tarsus Pharmaceuticals
TARS
|
2.95 B | $ 76.79 | 4.0 % | $ 3.21 B | USA |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
250 M | - | - | $ 1.62 B |  Israel |
 |
Bio-Techne Corporation
TECH
|
11 B | $ 72.8 | -0.03 % | $ 11.4 B | USA |
 |
Cabaletta Bio
CABA
|
253 M | $ 1.46 | 0.69 % | $ 147 M | USA |
 |
Gilead Sciences
GILD
|
176 B | $ 169.72 | -0.67 % | $ 211 B | USA |
 |
PhaseBio Pharmaceuticals
PHAS
|
226 M | - | 7.4 % | $ 6.29 M | USA |
 |
Forma Therapeutics Holdings
FMTX
|
452 M | - | - | $ 958 M | USA |
 |
Blueprint Medicines Corporation
BPMC
|
6.74 B | - | - | $ 8.14 B | USA |
 |
Horizon Therapeutics Public Limited Company
HZNP
|
22.9 B | - | - | $ 26.6 B |  Irlanda |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
-61.5 M | $ 3.86 | -5.98 % | $ 32.9 M | USA |
 |
Gossamer Bio
GOSS
|
365 M | $ 11.6 | 2.84 % | $ 2.65 B | USA |
 |
Provention Bio
PRVB
|
1.86 B | - | - | $ 2.37 B | USA |
 |
DBV Technologies S.A.
DBVT
|
2.69 B | $ 11.85 | 2.95 % | $ 1.65 B |  France |
 |
Taysha Gene Therapies
TSHA
|
1.23 B | $ 4.26 | -0.35 % | $ 1.36 B | USA |
 |
Reata Pharmaceuticals
RETA
|
1.6 B | - | - | $ 6.29 B | USA |
 |
iTeos Therapeutics
ITOS
|
248 M | - | - | $ 411 M | USA |
 |
PolarityTE
PTE
|
-900 K | - | -0.82 % | $ 1.78 M | USA |
 |
Kronos Bio
KRON
|
-47.8 M | - | 1.49 % | $ 50.8 M | USA |
 |
United Therapeutics Corporation
UTHR
|
22.8 B | $ 595.86 | 1.23 % | $ 26.4 B | USA |
 |
Landos Biopharma
LABP
|
16.9 M | - | 0.58 % | $ 144 M | USA |
 |
Vericel Corporation
VCEL
|
1.92 B | $ 59.45 | 0.7 % | $ 2.99 B | USA |
 |
Veracyte
VCYT
|
2.78 B | $ 25.08 | 4.24 % | $ 1.97 B | USA |
 |
Advaxis
ADXS
|
-3.02 M | - | -9.65 % | $ 45.9 M | USA |
 |
Viking Therapeutics
VKTX
|
3.09 B | $ 28.63 | -0.1 % | $ 3.23 B | USA |
 |
vTv Therapeutics
VTVT
|
-63.5 M | $ 21.72 | 3.4 % | $ 87.1 M | USA |
 |
CNS Pharmaceuticals
CNSP
|
-2.04 M | $ 3.62 | -5.97 % | $ 1.6 M | USA |
 |
Trevena
TRVN
|
20.4 M | - | -46.58 % | $ 31.8 M | USA |
 |
Calithera Biosciences
CALA
|
-17.2 M | - | -10.95 % | $ 876 K | USA |
 |
InflaRx N.V.
IFRX
|
60.9 M | $ 1.18 | -2.48 % | $ 79.4 M |  Germany |
 |
Wave Life Sciences Ltd.
WVE
|
2.11 B | $ 3.42 | -0.15 % | $ 577 M |  Singapore |
 |
Exicure
XCUR
|
35.4 M | $ 1.05 | -2.78 % | $ 6.61 M | USA |
 |
Xenon Pharmaceuticals
XENE
|
2.24 B | $ 42.1 | 1.72 % | $ 3.34 B |  Canada |
 |
Xeris Pharmaceuticals
XERS
|
1.23 B | $ 16.51 | 4.3 % | $ 2.65 B | USA |
 |
X4 Pharmaceuticals
XFOR
|
66 M | $ 3.24 | -0.31 % | $ 137 M | USA |
 |
Xencor
XNCR
|
1.08 B | $ 39.98 | 1.5 % | $ 2.97 B | USA |
 |
Immunome
IMNM
|
1.28 B | $ 19.08 | 2.31 % | $ 1.67 B | USA |
 |
Molecular Templates
MTEM
|
29.7 M | - | -23.43 % | $ 495 K | USA |
 |
Virpax Pharmaceuticals
VRPX
|
1.81 M | - | -45.12 % | $ 2.85 M | USA |
 |
22nd Century Group
XXII
|
1.92 M | $ 1.57 | 10.56 % | $ 289 K | USA |
 |
Oncorus
ONCR
|
59.4 M | - | -8.54 % | $ 3.19 M | USA |
 |
Zai Lab Limited
ZLAB
|
21.4 B | $ 26.42 | -0.04 % | $ 28.9 B |  China |
 |
Zoetis
ZTS
|
65.9 B | $ 82.56 | 0.12 % | $ 36.6 B | USA |
 |
BioXcel Therapeutics
BTAI
|
127 M | $ 0.07 | 9.81 % | $ 855 K | USA |
 |
Navidea Biopharmaceuticals
NAVB
|
19.5 M | - | -2.99 % | $ 2.47 M | USA |
 |
Stealth BioTherapeutics Corp
MITO
|
499 M | - | - | $ 23.9 M | USA |
 |
Acer Therapeutics
ACER
|
38.2 M | - | 2.71 % | $ 14 M | USA |
 |
Turning Point Therapeutics
TPTX
|
1.92 B | - | -0.13 % | $ 3.73 B | USA |
 |
OncoSec Medical Incorporated
ONCS
|
26.7 M | - | 31.87 % | $ 1.61 M | USA |
 |
BioDelivery Sciences International
BDSI
|
330 M | - | -4.8 % | $ 255 M | USA |